United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read General business news Wabtec to strengthen digital intelligence with $1.8bn Evident deal Wabtec Corporation has unveiled its plan to acquire Evident’s Inspection Technologies division, formerly part of Olympus Corporation’s Scientific… byPallavi MadhirajuJanuary 14, 2025